Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure.
about
Oxygen demand of perfused heart preparations: how electromechanical function and inadequate oxygenation affect physiology and optical measurementsFunctional response of the isolated, perfused normoxic heart to pyruvate dehydrogenase activation by dichloroacetate and pyruvateAssociation between high mobility group box‑1 protein expression and cell death in acute pancreatitisCompetition of pyruvate with physiological substrates for oxidation by the heart: implications for studies with hyperpolarized [1-13C]pyruvate.An increase in the redox state during reperfusion contributes to the cardioprotective effect of GIK solution.The positive inotropic effect of pyruvate involves an increase in myofilament calcium sensitivity.Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF.High-mobility group box 1 protein and its role in severe acute pancreatitis.Research strategies in the study of the pro-oxidant nature of polyphenol nutraceuticals.Pyruvate-fortified resuscitation stabilizes cardiac electrical activity and energy metabolism during hypovolemia.Acetate transiently inhibits myocardial contraction by increasing mitochondrial calcium uptake.Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cellsMetabolic cardioprotection by pyruvate: recent progress.Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusionPyruvate stabilizes electrocardiographic and hemodynamic function in pigs recovering from cardiac arrest.Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.Cardiovascular applications of hyperpolarized contrast media and metabolic tracers.Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.Role of mitochondrial phosphate carrier in metabolism-secretion coupling in rat insulinoma cell line INS-1.Relationship between ischaemic time and ischaemia/reperfusion injury in isolated Langendorff-perfused mouse hearts.Structure and lipophilicity--the keys to understanding the function of pyruvate derivatives for ischemia/reperfusion?Mass isotopomer study of anaplerosis from propionate in the perfused rat heart.Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state.Acyloin production from aldehydes in the perfused rat heart: the potential role of pyruvate dehydrogenaseShort-term hibernation in adult cardiomyocytes is PO(2) dependent and Ca(2+) mediated.Acute hibernation decreases myocardial pyruvate carboxylation and citrate release.Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock.Cyclic fluctuations in the cardiac performance of the isolated Langendorff-perfused mouse heart: pyruvate abolishes the fluctuations and has an anti-ischaemic effect.Acetoacetate augments beta-adrenergic inotropism of stunned myocardium by an antioxidant mechanism.Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart.Pyruvate modulates cardiac sarcoplasmic reticulum Ca2+ release in rats via mitochondria-dependent and -independent mechanisms.The intermediary metabolite pyruvate attenuates stunning and reduces infarct size in in vivo porcine myocardium.Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons.Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure.Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat hearts.Ethyl pyruvate protects colonic anastomosis from ischemia-reperfusion injury.Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.Pyruvate-fortified cardioplegia suppresses oxidative stress and enhances phosphorylation potential of arrested myocardium.Pyruvate-enriched resuscitation: metabolic support of post-ischemic hindlimb muscle in hypovolemic goats.
P2860
Q26830067-A61EB64A-9D9B-437C-862B-8853CE141C52Q28264512-2034272A-D970-4293-9864-D017548CD2ACQ33702146-4A5EE1AB-4C78-4F5B-A2C0-E2015CAB60DCQ33840708-FF4CDA42-6018-4F1C-B238-A4B28165A8F2Q34337997-760B1C8C-0145-495A-A6DD-D538F8964BC5Q34730765-3A6EC112-4D9C-4EBC-98AB-EF6A35B205B8Q34733351-8A82E549-E77F-45DB-9990-B6C26D17C379Q35045701-930F7093-0103-4202-BB97-F4E323B6C546Q35101858-B3F4BA10-4599-45BD-A6E3-3478388D96CEQ35139433-D7BC59FA-915A-46F6-8C00-4C3D640EFA21Q35501642-A17AA603-B84A-4B2F-AF59-838A674F002CQ35753977-B4C78E52-7135-4335-AFAA-C7D271068F0EQ36177933-9A708DB5-B748-4A52-98AE-E119B2A12CECQ36234120-BE211CC9-328E-4C46-873E-FF54B14F0E65Q37038787-F891FD4C-AAA7-4A3B-8122-2B052710D4EBQ37071382-633A884A-C355-481F-B2E1-8441FA6E4678Q37366616-6AAE4AAD-CF4F-4AF5-8DD5-CA6F9ED6DDD1Q37637734-A57B1AEF-CA2B-460A-85C6-4D74ADC0101EQ38087991-AECE7801-378C-4467-AD9A-CCCF8A7B6C06Q39603121-390E6372-8516-4199-8A15-603D62A0D6CCQ40708316-44C4B8B6-9469-4C78-91A6-F84F2AAE0F6DQ41876398-E1AFC0C4-03FF-49FE-B70E-069D9862B909Q41959288-2EBD3EE0-2DAE-4FE2-9EB9-E57BD11BD5BDQ42495011-F8F9C28E-B33B-4FEB-B8F3-6CE239579742Q42812001-62847E4D-9AB6-4972-AD1E-E9DAD12801C4Q43512677-BA16219A-E787-479A-A85A-B55C1BA6C97BQ43737901-F8D1F92E-67D5-4C5F-8A26-D69F625FDC60Q44028476-F07A9EFE-DB65-46D1-9130-D2EC78634D2CQ44093924-778EB331-35B2-45CF-ADB6-AD1B8BA03D18Q44321361-78C38A6A-0EF5-4405-97A0-F966B68F7050Q44470060-8739A084-2E66-4C88-AE73-7CC458759426Q44489966-F41C9547-36D0-4874-9769-D9F72C554A01Q44612927-3365CEBD-772E-4425-AE6D-C46E82A9F2F5Q44689992-883B99F0-6AAA-43CA-B015-2AF84EB90738Q44776913-6EC7722F-B2C3-4B57-B5A9-BEAD077045CCQ45069870-7DAC9CFC-C00B-4054-BD37-A7161724A308Q46209458-65A58A3B-8176-4D45-82B3-3E3BCE299256Q46258459-399CF600-0E2D-43F7-94EC-1A7E707F27BDQ46502772-11A8110B-F049-4478-B9FF-6955ED2F9F05Q46947398-8D296B23-BE68-440D-96FF-DE0217D52658
P2860
Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@en
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@nl
type
label
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@en
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@nl
prefLabel
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@en
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@nl
P2860
P1433
P1476
Pyruvate-enhanced phosphorylat ...... perfusion contractile failure.
@en
P2093
P2860
P304
P356
10.1111/J.1432-1033.1989.TB14637.X
P407
P577
1989-03-01T00:00:00Z